Affluent Partners Holdings Ltd

Baijin Life Science Holdings Limited, together with its subsidiaries, is involved in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People's Republic of China, the United States, and internationally. It operates through three segments: Jewellery Business, Skincare Business, and Strategic Investment. The company also engages in research and development of cellular and large molecule drugs, clinical research services, and the development and sale of medical devices, cosmetics, and private care products under the FO brand. It was formerly known as Affluent Partners Holdings Limited and changed its name to Baijin Life Science Holdings Limited in December 2024. Incorporated in 2014, it is based in Wan Chai, Hong Kong.